Avantra Partners with TGen Drug Development to Build Assays for Biomarker Workstation

Avantra said that TD2's pharma clients could use its platform to identify appropriate biomarkers for use with drugs in development.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.